BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25680311)

  • 21. Impact of fluoroquinolone prophylaxis during neutropenia on bloodstream infection: Data from a surveillance program in 8755 patients receiving high-dose chemotherapy for haematologic malignancies between 2009 and 2014.
    Kern WV; Weber S; Dettenkofer M; Kaier K; Bertz H; Behnke M; Weisser M; Götting T; Widmer AF; Theilacker C;
    J Infect; 2018 Jul; 77(1):68-74. PubMed ID: 29883599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology and outcomes of bloodstream infection in patients with cirrhosis.
    Bartoletti M; Giannella M; Caraceni P; Domenicali M; Ambretti S; Tedeschi S; Verucchi G; Badia L; Lewis RE; Bernardi M; Viale P
    J Hepatol; 2014 Jul; 61(1):51-8. PubMed ID: 24681345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nosocomial Klebsiella pneumoniae bacteraemia in adult cancer patients--characteristics of neutropenic and non-neutropenic patients.
    Lin YT; Liu CJ; Fung CP; Tzeng CH
    Scand J Infect Dis; 2011 Aug; 43(8):603-8. PubMed ID: 21539500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for and influence of bloodstream infections on mortality: a 1-year prospective study in a Greek intensive-care unit.
    Pratikaki M; Platsouka E; Sotiropoulou C; Vassilakopoulos T; Paniara O; Roussos C; Routsi C
    Epidemiol Infect; 2009 May; 137(5):727-35. PubMed ID: 18796170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects.
    Velasco E; Byington R; Martins CS; Schirmer M; Dias LC; Gonçalves VM
    Clin Microbiol Infect; 2004 Jun; 10(6):542-9. PubMed ID: 15191383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study).
    Albasanz-Puig A; Gudiol C; Puerta-Alcalde P; Ayaz CM; Machado M; Herrera F; Martín-Dávila P; Laporte-Amargós J; Cardozo C; Akova M; Álvarez-Uría A; Torres D; Fortún J; García-Vidal C; Muñoz P; Bergas A; Pomares H; Mercadal S; Durà-Miralles X; García-Lerma E; Pallarès N; Carratalà J
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0004521. PubMed ID: 33972253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia.
    González-Barca E; Fernández-Sevilla A; Carratalá J; Salar A; Peris J; Grañena A; Gudiol F
    Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):539-44. PubMed ID: 10517190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies.
    Todeschini G; Tecchio C; Borghero C; D'Emilio A; Pegoraro E; de Lalla F; Benedetti P; Spolaore P; Pellizzer G
    J Infect; 2006 Oct; 53(4):266-73. PubMed ID: 16388852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome.
    Anatoliotaki M; Valatas V; Mantadakis E; Apostolakou H; Mavroudis D; Georgoulias V; Rolston KV; Kontoyiannis DP; Galanakis E; Samonis G
    Infection; 2004 Apr; 32(2):65-71. PubMed ID: 15057569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of multidrug resistant isolates and mortality predictors in patients with solid tumors or hematological malignancies.
    Bastug A; Kayaaslan B; Kazancioglu S; But A; Aslaner H; Akinci E; Yetkin MA; Kanyilmaz D; Eren SS; Bodur H
    J Infect Dev Ctries; 2015 Oct; 9(10):1100-7. PubMed ID: 26517485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States.
    Wisplinghoff H; Seifert H; Wenzel RP; Edmond MB
    Clin Infect Dis; 2003 May; 36(9):1103-10. PubMed ID: 12715303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival in neutropenic patients with severe sepsis or septic shock.
    Legrand M; Max A; Peigne V; Mariotte E; Canet E; Debrumetz A; Lemiale V; Seguin A; Darmon M; Schlemmer B; Azoulay E
    Crit Care Med; 2012 Jan; 40(1):43-9. PubMed ID: 21926615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive-care-unit-acquired bloodstream infections in a regional critically ill population.
    Laupland KB; Kirkpatrick AW; Church DL; Ross T; Gregson DB
    J Hosp Infect; 2004 Oct; 58(2):137-45. PubMed ID: 15474185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bloodstream infection in patients with head and neck cancer: a major challenge in the cetuximab era.
    Marín M; Gudiol C; Castet F; Oliva M; Peiró I; Royo-Cebrecos C; Carratalà J; Mesia R
    Clin Transl Oncol; 2019 Feb; 21(2):187-196. PubMed ID: 29948973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute respiratory failure in neutropenic patients is associated with a high post-ICU mortality.
    Mokart D; Azoulay E; Schnell D; Bourmaud A; Kouatchet A; Pène F; Lemiale V; Lambert J; Bruneel F; Vincent F; Legrand M; Rabbat A; Darmon M
    Minerva Anestesiol; 2013 Oct; 79(10):1156-63. PubMed ID: 23857442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Empirical Antibiotic Regimens on Mortality in Neutropenic Patients with Bloodstream Infection Presenting with Septic Shock.
    Chumbita M; Puerta-Alcalde P; Gudiol C; Garcia-Pouton N; Laporte-Amargós J; Ladino A; Albasanz-Puig A; Helguera C; Bergas A; Grafia I; Sastre E; Suárez-Lledó M; Durà X; Jordán C; Marco F; Condom M; Castro P; Martínez JA; Mensa J; Soriano A; Carratalà J; Garcia-Vidal C
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0174421. PubMed ID: 34843387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients.
    Horasan ES; Ersoz G; Tombak A; Tiftik N; Kaya A
    Med Sci Monit; 2011 May; 17(5):CR304-9. PubMed ID: 21525814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients.
    Bartoletti M; Giannella M; Lewis R; Caraceni P; Tedeschi S; Paul M; Schramm C; Bruns T; Merli M; Cobos-Trigueros N; Seminari E; Retamar P; Muñoz P; Tumbarello M; Burra P; Torrani Cerenzia M; Barsic B; Calbo E; Maraolo AE; Petrosillo N; Galan-Ladero MA; D'Offizi G; Bar Sinai N; Rodríguez-Baño J; Verucchi G; Bernardi M; Viale P;
    Clin Microbiol Infect; 2018 May; 24(5):546.e1-546.e8. PubMed ID: 28818628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care.
    Harbarth S; Ferrière K; Hugonnet S; Ricou B; Suter P; Pittet D
    Arch Surg; 2002 Dec; 137(12):1353-9; discussion 1359. PubMed ID: 12470098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years.
    Peri AM; Edwards F; Henden A; Harris PNA; Chatfield MD; Paterson DL; Laupland KB
    Clin Exp Med; 2023 Dec; 23(8):4563-4573. PubMed ID: 37815735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.